In the US, Parcopa (carbidopa/levodopa systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat GTP-CH Deficiency, Neuroleptic Malignant Syndrome, Parkinson's Disease and Restless Legs Syndrome.
US matches:
- Parcopa Orally Disintegrating Tablets
- Parcopa
Ingredient matches for Parcopa
Carbidopa
Carbidopa is reported as an ingredient of Parcopa in the following countries:
- United States
Levodopa
Levodopa is reported as an ingredient of Parcopa in the following countries:
- United States
International Drug Name Search
No comments:
Post a Comment